|
Immunotherapy
Citations 161-170 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis
- Arnon P. Kater, Frank Dicker, Massimo Mangiola, Kate Welsh, Richard Houghten, John Ostresh, Adel Nefzi, John C. Reed, Clemencia Pinilla, and Thomas J. Kipps
Blood 2005; 106: 1742-1748.
[Abstract]
[Full text]
[PDF]
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
- Emanuela Zappia, Simona Casazza, Enrico Pedemonte, Federica Benvenuto, Ivan Bonanni, Ezio Gerdoni, Debora Giunti, Antonella Ceravolo, Francesco Cazzanti, Francesco Frassoni, Gianluigi Mancardi, and Antonio Uccelli
Blood 2005; 106: 1755-1761.
[Abstract]
[Full text]
[PDF]
The fully human anti-CD30 antibody 5F11 activates NF- B and sensitizes lymphoma cells to bortezomib-induced apoptosis
- Boris Böll, Hinrich Hansen, Friederike Heuck, Katrin Reiners, Peter Borchmann, Achim Rothe, Andreas Engert, and Elke Pogge von Strandmann
Blood 2005; 106: 1839-1842.
[Abstract]
[Full text]
[PDF]
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody
- Paul J. Tacken, I. Jolanda M. de Vries, Karlijn Gijzen, Ben Joosten, Dayang Wu, Russell P. Rother, Susan J. Faas, Cornelis J. A. Punt, Ruurd Torensma, Gosse J. Adema, and Carl G. Figdor
Blood 2005; 106: 1278-1285.
[Abstract]
[Full text]
[PDF]
Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner
- Yun Guo, Hironari Niiya, Taichi Azuma, Naoyuki Uchida, Yoshihiro Yakushijin, Ikuya Sakai, Takaaki Hato, Masuhiro Takahashi, Satoru Senju, Yasuharu Nishimura, and Masaki Yasukawa
Blood 2005; 106: 1415-1418.
[Abstract]
[Full text]
[PDF]
B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis
- Kieron Dunleavy, Frances Hakim, Hyun Kyung Kim, John E. Janik, Nicole Grant, Takayuki Nakayama, Therese White, George Wright, Larry Kwak, Ronald Gress, Giovanna Tosato, and Wyndham H. Wilson
Blood 2005; 106: 795-802.
[Abstract]
[Full text]
[PDF]
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report
- Miriam Galbusera, Elena Bresin, Marina Noris, Sara Gastoldi, Daniela Belotti, Cristina Capoferri, Erica Daina, Paolo Perseghin, Friedrich Scheiflinger, Fadi Fakhouri, Jean-Pierre Grünfeld, Enrico Pogliani, and Giuseppe Remuzzi
Blood 2005; 106: 925-928.
[Abstract]
[Full text]
[PDF]
Identification and characterization of epitopes of the receptor for hyaluronic acid–mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2–positive patients with acute myeloid leukemia
- Jochen Greiner, Li Li, Mark Ringhoffer, Thomas F. E. Barth, Krzysztof Giannopoulos, Phillipe Guillaume, Gerd Ritter, Markus Wiesneth, Hartmut Döhner, and Michael Schmitt
Blood 2005; 106: 938-945.
[Abstract]
[Full text]
[PDF]
A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma
- Francine Foss, Marie France Demierre, and Gina DiVenuti
Blood 2005; 106: 454-457.
[Abstract]
[Full text]
[PDF]
Generation of tumor-specific, HLA class I–restricted human Th1 and Tc1 cells by cell engineering with tumor peptide–specific T-cell receptor genes
- Takemasa Tsuji, Masaki Yasukawa, Junko Matsuzaki, Takayuki Ohkuri, Kenji Chamoto, Daiko Wakita, Taichi Azuma, Hironari Niiya, Hiroyuki Miyoshi, Kiyotaka Kuzushima, Yoshihiro Oka, Haruo Sugiyama, Hiroaki Ikeda, and Takashi Nishimura
Blood 2005; 106: 470-476.
[Abstract]
[Full text]
[PDF]
|
|
